hepatitis C

Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
TheStreet.com
Tue, 05/19/15 - 09:50 am
M&A
social media
twitter
Gilead Sciences
hepatitis C
Achillion
Hep C patient sues Blue Cross for blocking access to Harvoni
Fierce Pharma
Mon, 05/18/15 - 09:42 pm
hepatitis C
Harvoni
insurance
Gilead Sciences
Gilead: Hep-C Prescriptions Fall, But Quarter Tracking Higher
Barron's
Sat, 05/16/15 - 02:05 pm
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Senator asks VA to yank patent on Gilead's Sovaldi to crush its price
Fierce Pharma
Wed, 05/13/15 - 11:33 am
Bernie Sanders
Gilead Sciences
Sovaldi
hepatitis C
drug pricing
Gilead Sciences: Hep-C Prcing in Japan Better Than Expected
Barron's
Wed, 05/13/15 - 11:23 am
Gilead Sciences
Japan
hepatitis C
Sovaldi
Abuse of Pain Pills Fuels Virus’s Spread, Confounding Regulators
Bloomberg
Fri, 05/8/15 - 09:06 am
hepatitis C
oxycontin
Purdue Pharma
Gilead puts new DTC ads behind its already-stellar Harvoni launch
Fierce Pharma Marketing
Wed, 05/6/15 - 02:00 pm
Gilead Sciences
Harvoni
drug ads
hepatitis C
AbbVie Pushing Hepatitis C Pipeline, But Is It Fast Enough?
Seeking Alpha
Wed, 04/29/15 - 09:57 am
AbbVie
hepatitis C
Viekira Pak
Japan
Europe
Gilead Will Keep Hepatitis C Dominance In Its Grip With Recent Trial Results
Seeking Alpha
Tue, 04/28/15 - 08:49 am
Gilead Sciences
Harvoni
hepatitis C
AbbVie
Bristol-Myers Squibb
Merck
Achillion
Bristol-Myers says hepatitis C drug combination succeeds in study
Yahoo/Reuters
Sun, 04/26/15 - 09:18 am
Bristol-Myers Squibb
hepatitis C
daclatasvir
Analyst: Biogen Will Miss On Tecfidera Sales; No Threat To Gilead's Harvoni
Yahoo/Benzinga
Fri, 04/24/15 - 10:35 am
Biogen
Tecfidera
Merck
Gilead Sciences
grazoprevir/elbasvir
Harvoni
hepatitis C
Gilead to Use a Give-Away Program in Georgia for Reducing Hepatitis C
WSJ Pharmalot
Thu, 04/23/15 - 08:03 pm
Gilead Sciences
hepatitis C
Sovaldi
Merck and Gilead square off in battle of the next-next-gen hep C combos
Fierce Biotech
Thu, 04/23/15 - 09:50 am
Merck
Gilead Sciences
hepatitis C
grazoprevir/elbasvir
GS-5816
GS-9857
Morningstar: Gilead Sciences To Grow Its Hepatitis C Market
Yahoo/Morningstar
Sun, 04/19/15 - 11:48 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
AbbVie moves closer to Japan's crowded hep C field with priority review nod
Fierce Pharma
Fri, 04/17/15 - 10:33 am
AbbVie
Japan
hepatitis C
Viekira Pak
Gilead Sciences Sparks Analyst Dispute Over Hep C Forecasts
TheStreet.com
Tue, 04/14/15 - 10:26 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
A New Fifty-Year-Old Hepatitis C Drug
Seeking Alpha
Sat, 04/11/15 - 10:18 am
hepatitis C
chlorcyclizine
Gilead: Little Hep C Competition, But What About Pricing?
Barron's
Fri, 04/10/15 - 03:50 pm
Gilead Sciences
Merck
AbbVie
hepatitis C
Gilead’s $1,000 Pill Is Hard for States to Swallow
WSJ Online
Wed, 04/8/15 - 05:32 pm
Gilead
hepatitis C
drug pricing
Harvoni
Sovaldi
Latest Merck, AbbVie Data Not A Threat To Gilead: Citi
Barron's
Wed, 04/8/15 - 12:05 pm
Merck
AbbVie
hepatitis C
Gilead Sciences
grazoprevir/elbasvir
Harvoni

Pages